Dr. Kinnari Patel is the former President, Head of R&D and Chief Operating Officer at Rocket Pharma, where she led global R&D and Technical Operations from discovery through late-stage development and manufacturing, including regulatory, clinical, CMC and quality. She helped raise about $1B, guided Rocket’s IPO, supported the Renovacor acquisition, scaled the team from 3 to about 300, launched Rocket University and built the Cranbury, NJ manufacturing site. Previously at AstraZeneca, Bristol-Myers Squibb, Novartis and Roche, she led programs across Phases I to IV and contributed to eight US and EU submissions, including Opdivo and Myalept. She holds a BS and PharmD, an EMBA from NYU Stern and completed the Harvard Business School AMP. She serves on ARM’s Board and the HBA Global Advisory Board.